Concord Biotech is trading -0.22% lower at Rs 1,347.60 as compared to its last closing price. Concord Biotech has been trading in the price range of 1,423.45 & 1,324.00. Concord Biotech has given 0.41% in this year & -1.39% in the last 5 days. Concord Biotech has TTM P/E ratio 53.34 as compared to the sector P/E of 22.69.There are 4 analysts who have initiated coverage on Concord Biotech. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 63.06 Crores in its last quarter.Listed peers of Concord Biotech include Torrent Pharmaceuticals (0.35%), Cipla (-2.52%), Sun Pharmaceutical Industries (-1.84%).The Mutual Fund holding in Concord Biotech was at 4.53% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Concord Biotech was at 8.03% in 30 Sep 2025. The FII holding has decreased from the last quarter.
Updated on Jan 19, 2026, 12:42 AM UTC
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,018.75 | 0.35 | 1,36,007.30 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,398.45 | -2.52 | 1,12,922.46 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Bearish | 1,669.20 | -1.84 | 4,00,487.56 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | Bearish | 6,233.95 | -1.93 | 1,65,491.79 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bearish | 1,175.65 | -0.91 | 98,110.38 | 18.63 | 3.14 | 0.63 | 2.34 |
| Meeting Date | Purpose |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
Concord Biotech is trading at 1347.60 as on Fri Jan 16 2026 10:20:05. This is -0.22% lower as compared to its previous closing price of 1350.55.
The market capitalization of Concord Biotech is 14098.08 Cr as on Fri Jan 16 2026 10:20:05.
The average broker rating on Concord Biotech is Buy. The breakup of analyst rating is given below -
The 52 wk high for Concord Biotech is 2451.65 whereas the 52 wk low is 1292.35
Concord Biotech can be analyzed on the following key metrics -
Concord Biotech reported a net profit of 371.64 Cr in 2025.
The Mutual Fund Shareholding was 4.53% at the end of 30 Sep 2025.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.